Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Viviana Simon and Florian Krammer.
Viviana Simon
Connection Strength
4.278
Florian Krammer
  1. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 04 08; 384(14):1372-1374.
    View in: PubMed
    Score: 0.934
  2. Serology assays to manage COVID-19. Science. 2020 06 05; 368(6495):1060-1061.
    View in: PubMed
    Score: 0.882
  3. Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms. iScience. 2021 Sep 24; 24(9):102937.
    View in: PubMed
    Score: 0.240
  4. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021 07 22; 184(15):3936-3948.e10.
    View in: PubMed
    Score: 0.237
  5. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors. EBioMedicine. 2021 Jun; 68:103401.
    View in: PubMed
    Score: 0.237
  6. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2021 02; 590(7844):146-150.
    View in: PubMed
    Score: 0.228
  7. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol. 2020 09; 58(1):e108.
    View in: PubMed
    Score: 0.225
  8. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 2020 06; 57(1):e100.
    View in: PubMed
    Score: 0.221
  9. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
    View in: PubMed
    Score: 0.220
  10. Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model. mSphere. 2018 Jan-Feb; 3(1).
    View in: PubMed
    Score: 0.188
  11. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell. 2021 08 09; 39(8):1028-1030.
    View in: PubMed
    Score: 0.060
  12. Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave. Nat Commun. 2021 06 08; 12(1):3463.
    View in: PubMed
    Score: 0.059
  13. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021 Jul; 2(7):e283-e284.
    View in: PubMed
    Score: 0.059
  14. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021 02 05; 371(6529).
    View in: PubMed
    Score: 0.058
  15. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 12 04; 370(6521):1227-1230.
    View in: PubMed
    Score: 0.057
  16. A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1629-1634.
    View in: PubMed
    Score: 0.057
  17. COVID-19: Staging of a New Disease. Cancer Cell. 2020 11 09; 38(5):594-597.
    View in: PubMed
    Score: 0.057
  18. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. Lancet Microbe. 2020 Nov; 1(7):e283-e289.
    View in: PubMed
    Score: 0.057
  19. Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020 07 17; 369(6501):297-301.
    View in: PubMed
    Score: 0.055
  20. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nat Commun. 2018 11 01; 9(1):4560.
    View in: PubMed
    Score: 0.050
  21. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance. J Clin Invest. 2018 11 01; 128(11):4992-4996.
    View in: PubMed
    Score: 0.049
  22. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice. J Virol. 2018 10 15; 92(20).
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.